MedTrace Logo

HM242-Gel vs Comparator

NCT04902651 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 73

Last updated 2022-07-19

No results posted yet for this study

Summary

The primary objective of the study is to demonstrate that the HM242-Gel performs at least comparably to INTRASITE Gel with regard to wound healing.

Conditions

  • Venous Leg Ulcer

Interventions

DEVICE

HM242-Gel

HM242-Gel compared to Intrasite Gel in patients with a venous leg ulcer

DEVICE

Intrasite Gel

HM242-Gel compared to Intrasite Gel in patients with a venous leg ulcer

Sponsors & Collaborators

  • B. Braun Ltd. Centre of Excellence Infection Control

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-21
Primary Completion
2022-01-05
Completion
2022-02-16

Countries

  • Czechia
  • Slovakia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04902651 on ClinicalTrials.gov